Sun.Sep 15, 2024

article thumbnail

Top clicks this week on Abnormal Returns

Abnormal Returns

Also on the site Elder financial fraud is only going up. Maybe AI can help. (abnormalreturns.com) Noted personal finance writer Jonathan Clements is dying. He still has plenty left to teach us. (abnormalreturns.com) Top clicks this week How the new AirPod Pros 2 could upend the hearing aid industry. (cnbc.com) Sometimes things really are different this time.

Portfolio 299
article thumbnail

10 Money Revelations in my 40s

A Wealth of Common Sense

I wrote a post almost 10 years ago about money revelations in my 30s. Here’s an updated version now that I’m approaching my mid-40s (dammit Father Time): 1. Lifestyle creep isn’t always bad. Yes, you need to live below your means, delay gratification and avoid overspending. But I am not a fan of living like a pauper when you’re younger just so you can have more money when you’re older.

138
138
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Sunday links: market mood swings

Abnormal Returns

Markets Mortgage rates are back to early 2023 levels. (axios.com) Nvidia ($NVDA) dominates the list of the biggest single-day market cap moves. (visualcapitalist.com) Strategy Are money market fund assets a bond substitute or stock substitute? (awealthofcommonsense.com) Why great companies don't always make for great stocks. (humbledollar.com) ETFs What's left to be ETF'd?

Marketing 276
article thumbnail

FOMC Preview: Fed to Cut Rates

Calculated Risk

Most analysts expect the FOMC will cut the federal funds rate at the meeting this week by 25bp lowering the target range to 5 to 5-1/4 percent. It is possible the FOMC will cut by 50bp. Currently market participants are split evenly between a 25bp and a 50bp cut this week. Market participants are also pricing in a total of 75bp in cuts by the November meeting, and between 100bp to 125bp in cuts by December.

Banking 120
article thumbnail

Less Stress, More Success: Accounting Best Practices & Processes for 2025

Speaker: Duke Heninger, Partner and Fractional CFO at Ampleo & Creator of CFO System

Are you ready to elevate your accounting processes for 2025? 🚀 Join us for an exclusive webinar led by Duke Heninger, a seasoned fractional CFO and CPA passionate about transforming back-office operations for finance teams. This session will cover critical best practices and process improvements tailored specifically for accounting professionals.

article thumbnail

6 items for your not-to-do list

Million Dollar Round Table (MDRT)

By Matt Pais, MDRT Content Specialist You may regularly make a to-do list, but how often do you make a not-to-do list? Try these tactics as an unconventional means of pushing yourself toward exceeding expectations, from past MDRT member Denny Kern Heath, of Kingston, Jamaica.

More Trending

article thumbnail

Want To Boost Your Forex Trading Income With Social Media? Discover How!

Trade Brains

Have you ever wondered how social media can transform the way you earn through forex affiliate marketing? The rise of social media has revolutionized affiliate marketing, making it a potent tool for earning commissions by referring customers to forex brands. This transformation presents a golden opportunity for those involved in trading for beginners and seasoned traders alike.

Media 59
article thumbnail

10 Sunday Reads

The Big Picture

My Sunday morning look at incompetency, corruption and policy failures: • Neither Elon Musk Nor Anybody Else Will Ever Colonize Mars : Mars does not have a magnetosphere. Any discussion of humans ever settling the red planet can stop right there, but of course it never does. Do you have a low-cost plan for, uh, creating a gigantic active dynamo at Mars’s dead core?

article thumbnail

Best Cancer Pharma stock in India 2024 to keep an eye on!

Trade Brains

India is emerging as a major player in the pharmaceutical industry, particularly in the development of cancer drugs. The rising number of cancer cases, both domestic and international, creates immense opportunities for pharmaceutical companies specializing in oncology treatments. As demand for affordable and effective cancer therapies increases, Indian companies are leading in innovation and production.